Xupeng Mu Selected Research

Xupeng Mu Research Topics

8	Neoplasms (Cancer) 01/2023 - 01/2017
3	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 07/2018
2	Neoplasm Metastasis (Metastasis) 10/2023 - 05/2021
1	Cognitive Dysfunction 05/2023
1	Dysbiosis 05/2023
1	Alzheimer Disease (Alzheimer's Disease) 05/2023
1	Cholangiocarcinoma 02/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023
1	Leukemia 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Human Influenza (Influenza) 02/2016

2	Therapeutic UsesIBA 01/2023 - 11/2022
2	Small Interfering RNA (siRNA)IBA 01/2023 - 05/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 05/2021
2	polydopamineIBA 05/2021 - 01/2020
1	cadherin 5IBA 10/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2023
1	Amyloid (Amyloid Fibrils)IBA 05/2023
1	Drug CombinationsIBA 01/2023
1	SurvivinIBA 01/2023
1	LigandsIBA 05/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2021
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020
1	snake venom protein C activatorIBA 01/2020
1	BI 2536IBA 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	Polo-Like Kinase 1IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2019
1	3' Untranslated Regions (3' UTR)IBA 07/2018
1	Untranslated Regions (Untranslated Region)IBA 07/2018
1	Mitogen-Activated Protein KinasesIBA 04/2018
1	Insulin (Novolin)FDA Link 04/2018
1	Human Serum Albumin FDA LinkGeneric 02/2016
1	VaccinesIBA 02/2016
1	Recombinant Fusion ProteinsIBA 02/2016

4	Therapeutics 05/2023 - 07/2018
2	Radiotherapy 02/2023 - 11/2022
2	Drug Therapy (Chemotherapy) 01/2023 - 11/2022
2	Photothermal Therapy 01/2020 - 01/2017
1	Photochemotherapy (Photodynamic Therapy) 11/2022
1	Castration 11/2022
1	Induced Hyperthermia (Thermotherapy) 11/2022
1	Immunotherapy 05/2021
1	Transplantation 01/2018